Citation Impact
Citing Papers
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Accurate de novo design of heterochiral protein–protein interactions
2024 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Harnessing innate immunity in cancer therapy
2019 Nature
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
2020
A Novel d ‐Peptide Identified by Mirror‐Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy
2020
Tumor-Associated Neutrophils in Cancer: Going Pro
2019
Works of Lu Han being referenced
Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells
2018
The phase I clinical study of CART targeting BCMA with humanized alpaca-derived single-domain antibody as antigen recognition domain.
2019
Clinical Value of Neutrophil-to-Lymphocyte Ratio as a Predictor of Prognosis of Retronectin ® -Activated Cytokine-Induced Killer Cell Therapy in Advanced Non-Small-Cell Lung Cancer
2018
Development and Evaluation of CART Targeting Bcma with Humanized Alpaca-Derived Single-Domain Antibody As Antigen Recognition Domain
2018